Filing Details
- Accession Number:
- 0000904454-10-000141
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-27 13:00:00
- Reporting Period:
- 2010-04-27
- Filing Date:
- 2010-04-27
- Accepted Time:
- 2010-04-27 17:00:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1298033 | Domain Partners Vi, L.p. | C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-27 | 4,451,745 | $0.00 | 4,451,745 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2010-04-27 | 378,028 | $11.00 | 4,829,773 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2010-04-27 | 1,631,866 | $0.00 | 1,631,866 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2010-04-27 | 1,109,970 | $0.00 | 1,109,970 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2010-04-27 | 1,141,486 | $0.00 | 1,141,486 | $0.00 |
Common Stock | Series C-1 Preferred Stock | Disposition | 2010-04-27 | 568,423 | $0.00 | 568,423 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- All outstanding shares of the Issuer's preferred stock were automatically converted into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration.